Back to Search Start Over

Amyloid Imaging, Cerebrospinal Fluid Biomarkers Predict Driving Performance Among Cognitively Normal Individuals.

Authors :
Roe CM
Barco PP
Head DM
Ghoshal N
Selsor N
Babulal GM
Fierberg R
Vernon EK
Shulman N
Johnson A
Fague S
Xiong C
Grant EA
Campbell A
Ott BR
Holtzman DM
Benzinger TL
Fagan AM
Carr DB
Morris JC
Source :
Alzheimer disease and associated disorders [Alzheimer Dis Assoc Disord] 2017 Jan-Mar; Vol. 31 (1), pp. 69-72.
Publication Year :
2017

Abstract

Postmortem brain studies of older drivers killed in car accidents indicate that many had Alzheimer disease (AD) neuropathologic changes. We examined whether AD biomarkers are related to driving performance among cognitively normal older adults. Individuals with normal cognition, aged 65+ years, and driving at least once per week, were recruited. Participants (N=129) took part in clinical assessments, a driving test, and positron emission tomography imaging with Pittsburgh compound B (PIB) and/or cerebrospinal fluid (CSF) collection. General linear models tested whether the number of driving errors differed as a function of each of the biomarker variables (mean cortical binding potential for PIB, and CSF Aβ42, tau, ptau181, tau/Aβ42, ptau181/Aβ42). Higher ratios of CSF tau/Aβ42, ptau181/Aβ42, and PIB mean cortical binding potential, were associated with more driving errors (P<0.05). Preclinical AD may have subtle cognitive and functional effects, which alone may go unnoticed. However, when combined, these changes may impact complex behaviors such as driving.<br />Competing Interests: Possible Conflicts of Interest: Dr. Roe has no conflicts of interest. Dr. Barco has no conflicts of interest. Dr. Head has no conflicts of interest. Dr. Ghoshal has no conflicts of interest. Ms. Selsor reports no disclosures and has no conflicts of interest. Dr. Babulal has no conflicts of interest. Ms. Fierberg reports no disclosures and has no conflicts of interest. Ms. Vernon reports no disclosures and has no conflicts of interest. Mr. Shulman reports no disclosures and has no conflicts of interest. Ms. Johnson reports no conflicts of interest. Mr. Fague has no conflicts of interest. Dr. Xiong has no conflicts of interest. Dr. Grant has no conflicts of interest. Ms. Campbell reports no disclosures and has no conflicts of interest. Dr. Ott reports no conflicts of interest. Dr. Holtzman has no conflicts of interest. Dr. Benzinger has no conflicts of interest. Dr. Fagan has no conflicts of interest. Dr. Carr has no conflicts of interest. Dr. Morris has no conficts of interest.

Details

Language :
English
ISSN :
1546-4156
Volume :
31
Issue :
1
Database :
MEDLINE
Journal :
Alzheimer disease and associated disorders
Publication Type :
Academic Journal
Accession number :
27128959
Full Text :
https://doi.org/10.1097/WAD.0000000000000154